Related Experiment Video
Updated: Apr 5, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Selection in the dopamine receptor 2 gene: a candidate SNP study.
Tobias Göllner1, Martin Fieder1
1Department of Anthropology, University of Vienna , Vienna , Austria.
This study investigated the dopamine receptor 2 gene (DRD2) for signs of natural selection. Researchers identified candidate single nucleotide polymorphisms (SNPs) under balancing selection, suggesting evolutionary adaptation.
Area of Science:
- Human Genetics
- Evolutionary Biology
- Neuroscience
Background:
- Dopamine is a key neurotransmitter implicated in brain function and diseases like schizophrenia.
- Schizophrenia treatment involves blocking dopamine receptors, specifically type 2.
- The dopamine receptor 2 gene (DRD2) is a potential target for evolutionary selection studies.
Purpose of the Study:
- To investigate whether the dopamine receptor 2 gene (DRD2) has undergone natural selection.
- To identify specific genetic variants within DRD2 that may be under selection pressure.
Main Methods:
- Utilized genotype data from the 1,000 Genomes project (Phase I) comprising 1,093 individuals across 14 populations.
- Analyzed single nucleotide polymorphisms (SNPs) within DRD2 using two distinct methods: an outlier approach and a Bayesian approach.
- Included SNPs with minor allele frequencies (MAFs) > 0.05 and > 0.01, totaling 151 and 246 SNPs, respectively.
Main Results:
- Identified nine candidate SNPs under balancing selection for MAF > 0.05 and two for MAF > 0.01.
- Observed weak indications of directional selection, deemed insufficient for definitive conclusions.
- Located all candidate SNPs within intronic regions; one (rs12574471) previously noted in literature.
- Pinpointed rs80215768 in a promoter-flanking region and rs74751335 within a transcription factor binding site.
Conclusions:
- The dopamine receptor 2 gene (DRD2) shows evidence of balancing selection.
- Specific SNPs within DRD2, particularly rs80215768 and rs74751335, warrant further investigation for their functional roles.
- Future research is encouraged to explore the implications of these selected DRD2 variants.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Incomplete Dominance
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Principles of Pharmacogenetics: Types of Genetic Variants

